These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17557276)

  • 1. Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M.
    Meding J; Urich M; Licha K; Reinhardt M; Misselwitz B; Fayad ZA; Weinmann HJ
    Contrast Media Mol Imaging; 2007; 2(3):120-9. PubMed ID: 17557276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability.
    Sirol M; Moreno PR; Purushothaman KR; Vucic E; Amirbekian V; Weinmann HJ; Muntner P; Fuster V; Fayad ZA
    Circ Cardiovasc Imaging; 2009 Sep; 2(5):391-6. PubMed ID: 19808627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging.
    Barkhausen J; Ebert W; Heyer C; Debatin JF; Weinmann HJ
    Circulation; 2003 Aug; 108(5):605-9. PubMed ID: 12835227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging.
    Sirol M; Itskovich VV; Mani V; Aguinaldo JG; Fallon JT; Misselwitz B; Weinmann HJ; Fuster V; Toussaint JF; Fayad ZA
    Circulation; 2004 Jun; 109(23):2890-6. PubMed ID: 15184290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.
    Phinikaridou A; Andia ME; Lavin B; Smith A; Saha P; Botnar RM
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early MR lymphography with gadofluorine M in rabbits.
    Misselwitz B; Platzek J; Weinmann HJ
    Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadofluorine-enhanced magnetic resonance imaging of carotid atherosclerosis in Yucatan miniswine.
    Koktzoglou I; Harris KR; Tang R; Kane BJ; Misselwitz B; Weinmann HJ; Lu B; Nagaraj A; Roth SI; Carroll TJ; McPherson DD; Li D
    Invest Radiol; 2006 Mar; 41(3):299-304. PubMed ID: 16481913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine.
    Kim SJ; Moon WK; Choi SH; Chang JM; Cho N
    Eur J Radiol; 2012 Aug; 81(8):1751-7. PubMed ID: 21477960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
    Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
    Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model.
    Frericks BB; Kühl AA; Loddenkemper C; Stroux A; Valdeig S; Hotz B; Misselwitz B; Hoffmann JC; Wacker FK
    Invest Radiol; 2011 Aug; 46(8):478-85. PubMed ID: 21512398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gadofluorine-M and Gd-DTPA for noninvasive staging of atherosclerotic plaque stability using MRI.
    Ronald JA; Chen Y; Belisle AJ; Hamilton AM; Rogers KA; Hegele RA; Misselwitz B; Rutt BK
    Circ Cardiovasc Imaging; 2009 May; 2(3):226-34. PubMed ID: 19808597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
    Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro labeling of glioma cells with gadofluorine M enhances T1 visibility without affecting glioma cell growth or motility.
    Nolte IS; Gungor S; Erber R; Plaxina E; Scharf J; Misselwitz B; Gerigk L; Przybilla H; Groden C; Brockmann MA
    Magn Reson Med; 2008 May; 59(5):1014-20. PubMed ID: 18429039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysferlin-deficient muscular dystrophy: gadofluorine M suitability at MR imaging in a mouse model.
    Schmidt S; Vieweger A; Obst M; Mueller S; Gross V; Gutberlet M; Steinbrink J; Taubert S; Misselwitz B; Luedemann L; Spuler S
    Radiology; 2009 Jan; 250(1):87-94. PubMed ID: 19001151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadofluorine m uptake in stem cells as a new magnetic resonance imaging tracking method: an in vitro and in vivo study.
    Giesel FL; Stroick M; Griebe M; Tröster H; von der Lieth CW; Requardt M; Rius M; Essig M; Kauczor HU; Hennerici MG; Fatar M
    Invest Radiol; 2006 Dec; 41(12):868-73. PubMed ID: 17099425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term assessment of contrast effects of gadofluorine M and gadofluorine P in magnetic resonance imaging of mice.
    Sheng F; Inoue Y; Kiryu S; Watanabe M; Ohtomo K
    Jpn J Radiol; 2012 Jan; 30(1):86-91. PubMed ID: 22135114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.